From October 1, 2023 to December 31, 2023, the company has repurchased 3,738,100 shares, representing 0.78% for ¥10,060.35 million. With this, the company has completed the repurchase of 13,627,300 shares, representing 2.81% for ¥37,244.18 million under the buyback announced on July 25, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,300 JPY | +1.34% | +2.77% | -8.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.59% | 6.86B | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B | |
-4.29% | 4.71B |
- Stock Market
- Equities
- 4528 Stock
- News Ono Pharmaceutical Co., Ltd.
- Tranche Update on Ono Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023.